Brophy Gerard's Form 4 filing
Avantor, Inc. (AVTR) · filed Mar 2, 2022
- Accession no.
- 0001722482-22-000067
- Filed
- Mar 2, 2022
- Trade date
- Mar 1, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $69.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brophy GerardCIK 0001776107 | Officer (EVP, Biopharma Production) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2022 | Common Stock | SSaleDisposed | −2,027 | $34.47 | −$69,870.69 | 136,221 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.